AI-assisted, human-published
09/04/2025 /Funding Events
LPOXY Therapeutics Secures $28 Million Series A Financing for C. difficile Infection Prevention Therapy
LPOXY Therapeutics, Inc. secures $28 million Series A financing from 5Horizons Ventures, LLC to develop non-antibiotic therapy for C. difficile infections.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com